Understanding Adverse Biological Effect Predictions Using Knowledge Graphs
Authors:
Erik Bryhn Myklebust,
Ernesto Jimenez-Ruiz,
Jiaoyan Chen,
Raoul Wolf,
Knut Erik Tollefsen
Abstract:
Extrapolation of adverse biological (toxic) effects of chemicals is an important contribution to expand available hazard data in (eco)toxicology without the use of animals in laboratory experiments. In this work, we extrapolate effects based on a knowledge graph (KG) consisting of the most relevant effect data as domain-specific background knowledge. An effect prediction model, with and without ba…
▽ More
Extrapolation of adverse biological (toxic) effects of chemicals is an important contribution to expand available hazard data in (eco)toxicology without the use of animals in laboratory experiments. In this work, we extrapolate effects based on a knowledge graph (KG) consisting of the most relevant effect data as domain-specific background knowledge. An effect prediction model, with and without background knowledge, was used to predict mean adverse biological effect concentration of chemicals as a prototypical type of stressors. The background knowledge improves the model prediction performance by up to 40\% in terms of $R^2$ (\ie coefficient of determination). We use the KG and KG embeddings to provide quantitative and qualitative insights into the predictions. These insights are expected to improve the confidence in effect prediction. Larger scale implementation of such extrapolation models should be expected to support hazard and risk assessment, by simplifying and reducing testing needs.
△ Less
Submitted 28 October, 2022;
originally announced October 2022.
Artificial intelligence-based locoregional markers of brain peritumoral microenvironment
Authors:
Zahra Riahi Samani,
Drew Parker,
Hamed Akbari,
Spyridon Bakas,
Ronald L. Wolf,
Steven Brem,
Ragini Verma
Abstract:
In malignant primary brain tumors, cancer cells infiltrate into the peritumoral brain structures which results in inevitable recurrence. Quantitative assessment of infiltrative heterogeneity in the peritumoral region, the area where biopsy or resection can be hazardous, is important for clinical decision making. Previous work on characterizing the infiltrative heterogeneity in the peritumoral regi…
▽ More
In malignant primary brain tumors, cancer cells infiltrate into the peritumoral brain structures which results in inevitable recurrence. Quantitative assessment of infiltrative heterogeneity in the peritumoral region, the area where biopsy or resection can be hazardous, is important for clinical decision making. Previous work on characterizing the infiltrative heterogeneity in the peritumoral region used various imaging modalities, but information of extracellular free water movement restriction has been limitedly explored. Here, we derive a unique set of Artificial Intelligence (AI)-based markers capturing the heterogeneity of tumor infiltration, by characterizing free water movement restriction in the peritumoral region using Diffusion Tensor Imaging (DTI)-based free water volume fraction maps. A novel voxel-wise deep learning-based peritumoral microenvironment index (PMI) is first extracted by leveraging the widely different water diffusivity properties of glioblastomas and brain metastases as regions with and without infiltrations in the peritumoral tissue. Descriptive characteristics of locoregional hubs of uniformly high PMI values are extracted as AI-based markers to capture distinct aspects of infiltrative heterogeneity. The proposed markers are applied to two clinical use cases on an independent population of 275 adult-type diffuse gliomas (CNS WHO grade 4), analyzing the duration of survival among Isocitrate-Dehydrogenase 1 (IDH1)-wildtypes and the differences with IDH1-mutants. Our findings provide a panel of markers as surrogates of infiltration that captures unique insight about underlying biology of peritumoral microstructural heterogeneity, establishing them as biomarkers of prognosis pertaining to survival and molecular stratification, with potential applicability in clinical decision making.
△ Less
Submitted 29 August, 2022;
originally announced August 2022.
